Podcasts about latest advances

Shannon Salvador, MD, MSc, FRCSC - Advancing Frontline Endometrial Cancer Care: Translating the Latest Advances in Immunotherapy Plus Chemotherapy Regimens to Practice

Alice YY Cheng, MD, FRCPC - Elevating Care for T2D: Translating the Latest Advances on Incretin-Based Therapies to Practice

Alice YY Cheng, MD, FRCPC - Elevating Care for T2D: Translating the Latest Advances on Incretin-Based Therapies to Practice

Talk 1: Prof Louise Emmett, St Vincent's Hospital Sydney: Latest advances in theranostics for oncologyTalk 2: Prof Shaneen Sandhu, Peter MacCallum Cancer Centre: Embedding translational science in radio medical oncology

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/COPE/IPCE information, and to apply for credit, please visit us at PeerView.com/GEH865. CME/COPE/IPCE credit will be available until March 20, 2026.Improving the Patient Experience in Geographic Atrophy: Are You Putting the Latest Advances Into Practice? In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Apellis Pharmaceuticals, Inc. and Astellas.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/COPE/IPCE information, and to apply for credit, please visit us at PeerView.com/GEH865. CME/COPE/IPCE credit will be available until March 20, 2026.Improving the Patient Experience in Geographic Atrophy: Are You Putting the Latest Advances Into Practice? In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Apellis Pharmaceuticals, Inc. and Astellas.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/COPE/IPCE information, and to apply for credit, please visit us at PeerView.com/GEH865. CME/COPE/IPCE credit will be available until March 20, 2026.Improving the Patient Experience in Geographic Atrophy: Are You Putting the Latest Advances Into Practice? In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Apellis Pharmaceuticals, Inc. and Astellas.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/COPE/IPCE information, and to apply for credit, please visit us at PeerView.com/GEH865. CME/COPE/IPCE credit will be available until March 20, 2026.Improving the Patient Experience in Geographic Atrophy: Are You Putting the Latest Advances Into Practice? In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Apellis Pharmaceuticals, Inc. and Astellas.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/COPE/IPCE information, and to apply for credit, please visit us at PeerView.com/GEH865. CME/COPE/IPCE credit will be available until March 20, 2026.Improving the Patient Experience in Geographic Atrophy: Are You Putting the Latest Advances Into Practice? In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Apellis Pharmaceuticals, Inc. and Astellas.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/COPE/IPCE information, and to apply for credit, please visit us at PeerView.com/GEH865. CME/COPE/IPCE credit will be available until March 20, 2026.Improving the Patient Experience in Geographic Atrophy: Are You Putting the Latest Advances Into Practice? In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Apellis Pharmaceuticals, Inc. and Astellas.Disclosure information is available at the beginning of the video presentation.

Did you know recent data reveal that around half of patients with early breast cancer and detectable circulating tumor DNA showed metastases on staging scans? Credit available for this activity expires: 1/15/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002143?ecd=bdc_podcast_libsyn_mscpedu

Despite significant advancements in healthcare, gaps in women's health continue to leave many underserved, as discussed by Dr. Will Van Derveer and Dr. Sara Gottfried Szal in their exploration of the evolving field of female care. Dr. Szal reflects on her medical journey, highlighting the shift from physician-centered models to personalized, patient-focused approaches and the urgent need to address biases and systemic barriers in women's healthcare. They emphasize the importance of equipping practitioners to address unique health challenges—such as stress, hormones, cardiometabolic health, and lifestyle changes. This discussion underscores the potential to transform medicine, fostering proactive and respectful care that empowers women across all life stages. Show notes: ●        Midwifery model advocates collaborative, patient-centered women's healthcare – 03:04 ●        Hormonal complexity reveals broader health treatment gaps - 07:52 ●        Advancing women's health: Understanding stress, treatment, longevity - 12:17 ●        Women's cardiovascular risks, disparities, and urgent awareness needed - 17:29   How you can help others in a big way... If you enjoy the Higher Practice Podcast, please leave a quick review on the Apple Podcast app. It makes a big difference in getting the word out to other people who will benefit from this podcast. Simply, click on the show on your podcast app>scroll down to the bottom of the episodes>click the ratings and reviews section>tap stars to rate>click write a review. To learn more, visit: https://psychiatryinstitute.com/ Interested in providing psychedelic therapy? Download our free ebook, Getting Started With Psychedelic Therapy: https://bit.ly/3NjBW9k Struggle with mental health? Download our free guide, 10 Must Know Supplements For Optimal Mental Health: https://bit.ly/4feDMob.  And when you download our free guide, you'll also get our bi-weekly newsletter Mind Matters, where we share great tips on how to optimize your mental health.

In this episode of Curing with Sound, three leading experts in focused ultrasound technology share their groundbreaking work in pancreatic cancer treatment. Dr. Feng Wu from Oxford University, Dr. Jae Young Lee from Seoul National University Hospital, and Dr. Joan Vidal-Jové from Barcelona's Comprehensive Tumor Center discuss their innovative approaches to treating one of medicine's most challenging cancers using noninvasive focused ultrasound techniques. The episode provides insights into the evolution and future of focused ultrasound technology in cancer treatment. The experts detail how their work addresses key challenges in pancreatic cancer treatment, from enhancing drug delivery to activating immune responses. Key Points: Focused ultrasound technology shows particular promise in addressing the unique challenges of pancreatic cancer, including the ability to precisely target tumors while preserving surrounding critical structures. Multiple treatment pathways are being explored simultaneously: thermal ablation (HIFU), mechanical stimulation for drug delivery enhancement, and histotripsy for immune system activation, offering new hope for patients with limited treatment options. Dr. Lee shares exciting results from his phase II clinical trial combining focused ultrasound with chemotherapy, achieving a 63% objective response rate. Dr. Wu discusses combining HIFU ablation with drug delivery to overcome limitations in treating pancreatic cancer. Dr. Vidal-Jové reveals how histotripsy treatment has shown remarkable immune system activation effects.  SHOW TRANSCRIPT ---------------------------- QUESTIONS? Email podcast@fusfoundation.org if you have a question or comment about the show, or if you would you like to connect about future guest appearances.  Email info@fusfoundation.org if you have questions about focused ultrasound or the Foundation.  FUSF SOCIAL MEDIA LinkedIn X Facebook Instagram TikTok YouTube FUSF WEBSITE https://www.fusfoundation.org SIGN UP FOR OUR FREE NEWSLETTER https://www.fusfoundation.org/newsletter-signup/ READ THE LATEST NEWSLETTER https://www.fusfoundation.org/the-foundation/news-media/newsletter/ DOWNLOAD "THE TUMOR" BY JOHN GRISHAM (FREE E-BOOK) https://www.fusfoundation.org/read-the-tumor-by-john-grisham/

In this episode, Ayesha spoke with Brent Lucas, CEO of Envoy Medical. Envoy Medical is a medical device company focused on providing cutting-edge technologies across the hearing loss spectrum. According to the National Institute of Deafness and Other Communication Disorders, 13 percent of people in the US 12 years of age and older have hearing loss in both ears, underscoring the importance of developing solutions to help this population. Brent Lucas has been the CEO of Envoy Medical Corporation for the last seven years. Brent is a lawyer by training and as a Medical Devices Executive, he has extensive experience leading across enterprise functions. He has over 15 years of experience in active implantables in the hearing health industry. Brent has a Bachelor's Degree from the University of St. Thomas and JD from the Mitchell Hamline School of Law. Tune into the episode to hear more about the innovative hearing solutions Envoy Medical currently offers and some of the ones under development. Also hear more about hearing health, including guidance on how to protect hearing, where the industry may be headed in the next few years, as well as the Hearing Device Coverage Clarification Act and where it currently stands. For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/ Follow Us on Social Media Twitter: https://twitter.com/Xtalks Instagram: https://www.instagram.com/xtalks/ Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured

Jian Zuo, CEO of Ting Therapeutics, discusses the latest updates on otoprotective agents for three conditions: antibiotic-induced hearing loss, cisplatin-induced hearing loss, and noise-induced hearing loss. Dr. Zuo explains the science behind the company's innovative drug candidates and how they aim to address the unmet need for hearing protection. Zuo provides an overview of Ting Therapeutics' preclinical research, outlining key findings on TT003 and other investigational compounds. The discussion focuses on the company's research process, detailing the progress of these drug candidates through preclinical testing and examining their potential relevance for patients at risk of hearing loss. Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and X (formerly Twitter): https://www.linkedin.com/company/this-week-in-hearing/ https://twitter.com/WeekinHearing

We discussed a few things including:1. Jordan's career journey2.  Historical progress3. Latest AI developments4. How we can leverage AI5. Trends, challenges and opportunities re AIJordan is an AI strategist and founder and host of Everyday AI. Everyday AI is a fast-growing media company helping everyday professionals grow their companies and careers with Generative AI through its daily livestream, podcast and newsletter.Everyday AI is a Top 10 tech podcast on Spotify, and Jordan has taught prompt engineering basics to thousands of people, from entrepreneurs and small business owners to software engineers and Fortune 100 execs. He's been a featured keynote speaker on GenAI, as well as a Coursera instructor for GenAI.Previously, Jordan was an award-winning multimedia journalist and also worked with companies like Nike and Jordan Brand before starting his own Chicago-based digital strategy company called Accelerant Agency.#podcast #AFewThingsPodcast

Welcome to the Oncology Brothers podcast! In this episode, hosts Drs. Rahul and Rohit Gosain are joined by Dr. Gilberto Lopes, Chief of Medical Oncology at the Sylvester Comprehensive Cancer Center, to discuss the highlights from the World Conference on Lung Cancer 2024. Join us as we dive into four key studies that could reshape our understanding and approach to lung cancer treatment: 1. Checkmate 816 vs. Checkmate 77T: An exploratory analysis of neoadjuvant chemoimmunotherapy and the ongoing debate about the benefits of post-operative immunotherapy. 2. SKIPPirr Study: Discover how prophylactic strategies can reduce infusion-related reactions with amivantamab. 3. HARMONi-2: A look at a novel PD-1 and VEGF inhibitor compared to Pembrolizumab in metastatic non-small cell lung cancer. 4. TROPION-Lung01: Insights into the performance of the antibody-drug conjugate Dato-DXd against docetaxel, particularly in non-squamous histology. Tune in for an informative discussion that highlights the latest advancements in lung cancer research and treatment strategies. Don't forget to like, subscribe, and check out our other episodes for more insights into the current standard of care in oncology! #OncologyBrothers #LungCancer #WCLC2024 #CancerResearch #MedicalOncology   Website: http://www.oncbrothers.com/ Twitter: https://twitter.com/oncbrothers Contact us at info@oncbrothers.com

Today on the Egg Whisperer Show, I'm delighted to be joined by Dr. Mathew Leonardi . As a world expert in endometriosis, Dr. Leonardi is known for finding innovative ways to diagnose and treat endometriosis. Additionally, he is an avid researcher, and I can't wait for him to share his research with us. You all know that I love talking about the latest technology and research around fertility, and this conversation is going to be jam packed with great info. Read the full show notes on Dr. Aimee's website.   Dr. Mathew Leonardi's website click here. Do you have questions about IVF?Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, September 16, 2024 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom.   Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org. Other ways to connect with Dr. Aimee and The Egg Whisperer Show: Subscribe to my YouTube channel for more fertility tips!Subscribe to the newsletter to get updates

In this episode of the Hey Joe Pet Pro Vod/Podcast, Joe speaks with Dennis Gnetz, the CEO of a leading Mobile Grooming Vehicle Conversion Company and long time industry friends of Paragon. Dennis shares a little of the history of Wag'n Tails and how they are celebrating 30 years in business in 2024. He recaps what he identifies as the Wag'n Tails team's most significant accomplishments in the past 30 years. Joe and Dennis look at the state of the pet grooming industry, and specifically the mobile grooming segment. There is great discussion about how mobile grooming differs from brick and mortar salons and the opportunities and challenges of each. Discussions continue to address safety and engineering importances for the Professional Pet Groomer as well as the Pet they are caring for when building mobile grooming vehicles and considering what options are best for the operator and the clients. Dennis provides a look at the product innovations in the mobile grooming niche, focusing on the Wag'n Tails CleanPower System and Mobile Grooming Software, as well as the new product models in the mobile grooming space.

Alzheimer's is a global health problem, with nearly 7 million people living with the disease in the United States alone. Tremendous gains have been made in the understanding of the science and basic biology underlying Alzheimer's and other dementias. These advances are leading to great strides in strategies for prevention, detection, diagnostics and therapeutic interventions.  The Alzheimer's Association is a global leader in research, mobilizing the field to advance the vision of a world without Alzheimer's and all other dementia. This presentation will include: Highlights in Early Detection and Diagnosis, Latest Advances in Clinical Trials, Treatments and Lifestyle Interventions, Risk Reduction, and Alzheimer's Association initiatives and how you can get involved. About the Speaker Claire Day has been on the staff of the Alzheimer's Association since 2001. She is the chief program officer at the Northern California and Northern Nevada Chapter and as such oversees all care and support operations and research initiatives. Day is a clinical social worker and in 2018 was appointed the Chapter Lead for the U.S. Study to Protect Brain Health Through Lifestyle Interventions to Reduce Risk in partnership with UC Davis. This is a two-year clinical trial to evaluate whether lifestyle interventions that simultaneously target multiple risk factors protect cognitive function in older adults at increased risk for cognitive decline. MLF ORGANIZER: Patrick O'Reilly   A Psychology Member-led Forum program. Forums at the Club are organized and run by volunteer programmers who are members of The Commonwealth Club, and they cover a diverse range of topics. Learn more about our Forums.   Learn more about your ad choices. Visit megaphone.fm/adchoices

Missed the last oncology meeting in Chicago or simply want to recap the highlights? This rapid-fire program was made for you! Credit available for this activity expires: 7/9/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001283?ecd=bdc_podcast_libsyn_mscpedu

Being ahead of the completion and seeking best practice in technology advancements can bring about a significant benefit for you when you're up against lots of other businesses in a competitive market. Here, Haitham Razagui from VASA discusses the benefits of being part of a community that is seeking global best practice for technicians, particularly with EV.  Listen in to learn and level up.  Whispering Loudly, The Workshop Whisperer's Podcast. Thanks to Titanium Sponsor, Mechanic Desk and Diamond Sponsor Ventavid. Find out more about the Workshop Whisperer - https://workshopwhisperer.com/ Want to find out how The Workshop Whisperer team can help put your auto repair shop on the path to business success? Head to https://www.workshopwhisperer.com/whisperingloudly to claim your free Workshop Success Session with the team.See omnystudio.com/listener for privacy information.

New technologies in AI, how to utilize them, ethics and much more with Fermin Leal. School PR Podcast Facebook Page https://www.facebook.com/SchoolPRpodcast Private School PR Podcast Facebook group: https://www.facebook.com/groups/245614517497877 Twitter: @SchoolPRpodcast, @PeachjarINC, and @Nicholsstrat National Communications Internship Collab Signup: https://forms.gle/QbouPNHWrBKWJzEE8 https://peachjar.com/  https://nicholsstrategies.com/

Dr.Adrian Owen, is a renowned neuroscientist and Professor at The Brain and Mind Institute at the University of Western Ontario in Canada and the Chief Scientific Officer at Creyos Health. He talks about the latest in his brain health research. Go to Creyos.com and take their free cognitive tests.You can get a copy of his book "Into the Gray Zone"on Amazon.Become a supporter of this podcast: https://www.spreaker.com/podcast/fearless-aging--2801795/support.

Do you have a parasite? Are all parasites bad and does everyone need to do a parasite cleanse? In this episode we talk all about parasites! We cover what they are, symptoms of infection, how to treat them…and quite frankly how many people in the wellness space are going overboard with the topic!    In this episode, we cover how common parasitic infections are, types of parasites, and symptoms of infection. We discuss testing for parasites, how some can actually benefit the human body, and our favorite research backed natural compounds to treat a parasitic infection. Plus we discuss our thoughts on coffee enemas, colonics, and how many cleanses are too harsh or go on for too long and can wreak havoc on the microbiome!   Also in this episode:  Beat the Bloat Live Class Starts April 10th - Grab Your Spot for Just $99 Trust Your Gut Women's Wellness Event in Buda April 24th What Are Parasites? How Does Infection Happen?Episode 347 Functional Approaches to Lyme Disease How Common Are Parasites? The global war against intestinal parasites—should we use a holistic approach? Types of Parasites Symptoms of Parasite InfectionNaturally Nourished Episode 131 Candida and SIBO Deep Dive Testing for ParasitesComprehensive Digestive Stool Analysis 3 Day + Parasitology Commensal and Beneficial Parasites5 reasons you might actually want to be infected by a parasite Compounds to Combat ParasitesBeat the Bloat Bundle ArtemisiaArtemisia absinthium L.—Importance in the History of Medicine, the Latest Advances in Phytochemistry and Therapeutical, Cosmetological and Culinary Uses - PMC Black Walnut - GI Reset NanoSilver Oregano Oil - Herbal ImmuneInhibition of enteric parasites by emulsified oil of oregano in vivo Food as MedicineBacteria Battling Chimichurri Pumpkin Seed Pesto Thoughts on Colonics and Coffee Enemas Preventing Future InfectionsGI Immune Builder Rebuild Spectrum Probiotic  Beat the Bloat Ebook - $5 off with code BTB5OFF   This episode is sponsored by: This episode is sponsored by Carnivore Snax, a delicious snack combining just 2 ingredients: meat and Redmond Real Salt! These melt-in-your-mouth meat pastries are like no other dehydrated meat product or jerky on the market. We love that Carnivore Snax are a pro-America brand who sources from US farmers practicing regenerative agriculture and are verified by the Savory Institute confirming their carbon sequestering status. Check out the ribeye, pork loin, brisket and leg of lamb for just a few of our favorites! Use code ALIMILLERRD to save 15% off your order and get free shipping on $125 or more at carnivoresnax.com and while you are there be sure to check out The Hunt Membership to gain access to exclusive cuts, cash back and more!   

This conversation explores the different categories of technology available in Australia for clinical treatments with Nadine Dilong, Editor Spa+Clinic. The importance of clinical imaging in the diagnosis and treatment planning process is emphasised. The discussion covers the use of lasers and light therapies for redness and pigmentation, with a focus on the different treatment options and considerations for different skin tones. The conversation also touches on the legislation and safety measures surrounding laser treatments. We discuss skin conditions such as pigmentation, acne and rosacea and offer technology solutions that may accelerate a multi- modality treatment approach.  Key Takeaways Clinical imaging is an important step in the diagnosis and treatment planning process for skin concerns. Laser and light therapies can be effective in treating redness and pigmentation, but the choice of treatment should be based on individual skin type and condition. Legislation and safety measures vary across different states in Australia, highlighting the importance of seeking treatment from qualified practitioners. Regular skincare and clinical imaging can help maintain skin health and prevent future concerns. A correct diagnosis is crucial for determining the appropriate treatment for different types of pigmentation. Multimodality treatments that combine various technologies and devices are becoming more popular in the field of aesthetics. Skincare plays a significant role in preparing the skin for laser and device treatments and maintaining the results. LED light therapy is a simple and effective at-home option for improving skin health. Different lasers and devices can be used to treat acne, acne scars, and pigmentation. CO2, erbium, and fractional lasers are commonly used for skin resurfacing. Laser coring and non-surgical lifting treatments offer alternatives to surgical procedures. Consumers should be cautious when navigating information on social media and seek expert advice. Chapters 00:00 Introduction and the Importance of Clinical Imaging03:16 Diagnosis and Technology in Skin Clinics06:25 Body Composition Analysis07:49 The Importance of Clinical Imaging for Treatment Results09:13 Skincare and Clinical Imaging13:15 Diagnosing Redness and Redness Treatment Options19:11 IPL and Photorejuvenation for Redness23:40 Legislation and Laser Treatment Safety27:38 Laser Treatment for Pigmentation31:45 Different Types of Pigmentation and the Importance of Correct Diagnosis34:24 Multimodality Treatments and the Full Range of Options35:20 The Partnership Between Skincare and Laser/Device Treatments39:08 LED Light Therapy and At-Home Options41:26 Treating Acne with Blue LED and Avicleer Laser45:43 Treating Acne Scars and Pigmentation with Lasers and Devices47:00 Resurfacing the Skin with CO2, Erbium, and Fractional Lasers52:34 Laser Coring and Non-Surgical Lifting Treatments58:25 RF Microneedling and Navigating Information on Social Media Watch the episode here:https://youtu.be/c5_6GcDHvAYSee omnystudio.com/listener for privacy information.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/GZR865. CME/MOC credit will be available until February 14, 2025.PATHway to Decoding the Impact of Cancer Immunotherapy: Latest Advances in Biomarker Testing and Pathologic Response Assessment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck & Co., Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerKurt A. Schalper, MD, PhD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; Agenus Inc.; AstraZeneca; Bristol Myers Squibb; CDR-Life Inc.; Clinica Alemana de Santiago; EMD Serono Inc.; F.Hoffmann-La Roche; Genmab A/S; Indaptus Therapeutics; Janssen Pharmaceuticals, Inc.; Merck Sharpe & Dohme; Moderna, Inc.; Molecular Templates, Inc.; OnCusp Therapeutics; Parthenon/Incendia Therapeutics; Repertoire Therapeutics; Sanofi; Sensei Biotherapeutics; Shattuck Labs, Inc.; and Takeda Pharmaceutical Company Limited.Grant/Research Support from Akoya Biosciences; AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; F. Hoffmann-La Roche; Lilly; Merck Sharpe & Dohme; Ribon Therapeutics; Surface Oncology; Takeda Pharmaceutical Company Limited; and Tesaro Inc./GSK.Speakers Bureau participant with Bristol Myers Squibb; Fluidigm Corporation; Genmab A/S; Merck & Co., Inc.; Sanofi; and Takeda Pharmaceutical Company Limited.Co-Chair/PlannerVamsidhar Velcheti, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Bristol Myers Squibb; Galvanize Therapeutics, Inc.; GSK; Merck & Co., Inc.; Novocure; TAIHO ONCOLOGY, INC.; and Takeda Pharmaceutical Company Limited.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/GZR865. CME/MOC credit will be available until February 14, 2025.PATHway to Decoding the Impact of Cancer Immunotherapy: Latest Advances in Biomarker Testing and Pathologic Response Assessment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck & Co., Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerKurt A. Schalper, MD, PhD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; Agenus Inc.; AstraZeneca; Bristol Myers Squibb; CDR-Life Inc.; Clinica Alemana de Santiago; EMD Serono Inc.; F.Hoffmann-La Roche; Genmab A/S; Indaptus Therapeutics; Janssen Pharmaceuticals, Inc.; Merck Sharpe & Dohme; Moderna, Inc.; Molecular Templates, Inc.; OnCusp Therapeutics; Parthenon/Incendia Therapeutics; Repertoire Therapeutics; Sanofi; Sensei Biotherapeutics; Shattuck Labs, Inc.; and Takeda Pharmaceutical Company Limited.Grant/Research Support from Akoya Biosciences; AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; F. Hoffmann-La Roche; Lilly; Merck Sharpe & Dohme; Ribon Therapeutics; Surface Oncology; Takeda Pharmaceutical Company Limited; and Tesaro Inc./GSK.Speakers Bureau participant with Bristol Myers Squibb; Fluidigm Corporation; Genmab A/S; Merck & Co., Inc.; Sanofi; and Takeda Pharmaceutical Company Limited.Co-Chair/PlannerVamsidhar Velcheti, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Bristol Myers Squibb; Galvanize Therapeutics, Inc.; GSK; Merck & Co., Inc.; Novocure; TAIHO ONCOLOGY, INC.; and Takeda Pharmaceutical Company Limited.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/GZR865. CME/MOC credit will be available until February 14, 2025.PATHway to Decoding the Impact of Cancer Immunotherapy: Latest Advances in Biomarker Testing and Pathologic Response Assessment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck & Co., Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerKurt A. Schalper, MD, PhD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; Agenus Inc.; AstraZeneca; Bristol Myers Squibb; CDR-Life Inc.; Clinica Alemana de Santiago; EMD Serono Inc.; F.Hoffmann-La Roche; Genmab A/S; Indaptus Therapeutics; Janssen Pharmaceuticals, Inc.; Merck Sharpe & Dohme; Moderna, Inc.; Molecular Templates, Inc.; OnCusp Therapeutics; Parthenon/Incendia Therapeutics; Repertoire Therapeutics; Sanofi; Sensei Biotherapeutics; Shattuck Labs, Inc.; and Takeda Pharmaceutical Company Limited.Grant/Research Support from Akoya Biosciences; AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; F. Hoffmann-La Roche; Lilly; Merck Sharpe & Dohme; Ribon Therapeutics; Surface Oncology; Takeda Pharmaceutical Company Limited; and Tesaro Inc./GSK.Speakers Bureau participant with Bristol Myers Squibb; Fluidigm Corporation; Genmab A/S; Merck & Co., Inc.; Sanofi; and Takeda Pharmaceutical Company Limited.Co-Chair/PlannerVamsidhar Velcheti, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Bristol Myers Squibb; Galvanize Therapeutics, Inc.; GSK; Merck & Co., Inc.; Novocure; TAIHO ONCOLOGY, INC.; and Takeda Pharmaceutical Company Limited.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/GZR865. CME/MOC credit will be available until February 14, 2025.PATHway to Decoding the Impact of Cancer Immunotherapy: Latest Advances in Biomarker Testing and Pathologic Response Assessment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck & Co., Inc.Disclosure PolicyAll relevant conflicts of interest have been mitigated prior to the commencement of the activity.Faculty/Planner DisclosuresCo-Chair/PlannerKurt A. Schalper, MD, PhD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AbbVie Inc.; Agenus Inc.; AstraZeneca; Bristol Myers Squibb; CDR-Life Inc.; Clinica Alemana de Santiago; EMD Serono Inc.; F.Hoffmann-La Roche; Genmab A/S; Indaptus Therapeutics; Janssen Pharmaceuticals, Inc.; Merck Sharpe & Dohme; Moderna, Inc.; Molecular Templates, Inc.; OnCusp Therapeutics; Parthenon/Incendia Therapeutics; Repertoire Therapeutics; Sanofi; Sensei Biotherapeutics; Shattuck Labs, Inc.; and Takeda Pharmaceutical Company Limited.Grant/Research Support from Akoya Biosciences; AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; F. Hoffmann-La Roche; Lilly; Merck Sharpe & Dohme; Ribon Therapeutics; Surface Oncology; Takeda Pharmaceutical Company Limited; and Tesaro Inc./GSK.Speakers Bureau participant with Bristol Myers Squibb; Fluidigm Corporation; Genmab A/S; Merck & Co., Inc.; Sanofi; and Takeda Pharmaceutical Company Limited.Co-Chair/PlannerVamsidhar Velcheti, MD, has a financial interest/relationship or affiliation in the form of:Consultant and/or Advisor for AstraZeneca; Bristol Myers Squibb; Galvanize Therapeutics, Inc.; GSK; Merck & Co., Inc.; Novocure; TAIHO ONCOLOGY, INC.; and Takeda Pharmaceutical Company Limited.Planning Committee and Reviewer DisclosuresPlanners, independent reviewers, and staff of PVI, PeerView Institute for Medical Education, do not have any relevant financial relationships related to this CE activity unless listed below.

We discussed a few things including:1. Jordan's entrepreneurial journey2. Everyday AI podcast + Newsletter3. Opps and Challenges related to #AI4. Forecast for 20245. Guidance for young and oldJordan is an AI strategist and founder and host of Everyday AI. Everyday AI is a fast-growing media company helping everyday professionals grow their companies and careers with Generative AI through its daily livestream, podcast and newsletter.Everyday AI is a Top 10 tech podcast on Spotify, and Jordan has taught prompt engineering basics to thousands of people, from entrepreneurs and small business owners to software engineers and Fortune 100 execs. He's been a featured keynote speaker on GenAI, as well as a Coursera instructor for GenAI.Previously, Jordan was an award-winning multimedia journalist and also worked with companies like Nike and Jordan Brand before starting his own Chicago-based digital strategy company called Accelerant Agency.#podcast #AFewThingsPodcast

CME credits: 1.00 Valid until: 17-01-2025 Claim your CME credit at https://reachmd.com/programs/cme/ascoesmo-2023-roundtable-contextualizing-the-latest-advances-in-her2-targeted-therapy-for-solid-tumors/16562/ HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as they examine the potential role for HER2-directed antibody-drug conjugates in treating advanced solid tumors and discuss the latest data around the efficacy and safety of these agents.

Today on the Egg Whisperer Show, I'm delighted to be joined by Dr. Mathew Leonardi . As a world expert in endometriosis, Dr. Leonardi is known for finding innovative ways to diagnose and treat endometriosis. Additionally, he is an avid researcher, and I can't wait for him to share his research with us. You all know that I love talking about the latest technology and research around fertility, and this conversation is going to be jam packed with great info. Read the full show notes on Dr. Aimee's website.   Dr. Mathew Leonardi's website click here. Do you have questions about IVF?Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, December 11, 2023 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom.   Get Dr. Aimee's brand new Conception Kit here. Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org. Other ways to connect with Dr. Aimee and The Egg Whisperer Show: Subscribe to my YouTube channel for more fertility tips!Subscribe to the newsletter to get updates

Stephen Chia, MD, FRCP(C) - Keeping Abreast of the Latest Advances in HER2-Positive Metastatic Breast Cancer Treatment: Clinical Implications for the Canadian Landscape

Are you up to date with developments in breast cancer? Join the specialists for the data most recently presented at the American oncology meeting. Credit available for this activity expires: 6/30/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/993869?ecd=bdc_podcast_libsyn_mscpedu

Bruton's tyrosine kinase (BTK) inhibitors have transformed the treatment landscape of chronic lymphocytic leukemia (CLL), with both covalent and non-covalent... The post CLL highlights at EHA 2023: latest advances with the use of BTK inhibitors appeared first on VJHemOnc.

Bruton's tyrosine kinase (BTK) inhibitors have transformed the treatment landscape of chronic lymphocytic leukemia (CLL), with both covalent and non-covalent... The post CLL highlights at EHA 2023: latest advances with the use of BTK inhibitors appeared first on VJHemOnc.

Do you know how to personalize treatment for your patients with metastatic breast cancer (mBC)? How can you incorporate emerging treatment strategies? Credit available for this activity expires: 6/12/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/993007?ecd=bdc_podcast_libsyn_mscpedu

Today on the Egg Whisperer Show, I'm delighted to be joined by Dr. Mathew Leonardi . As a world expert in endometriosis, Dr. Leonardi is known for finding innovative ways to diagnose and treat endometriosis. Additionally, he is an avid researcher, and I can't wait for him to share his research with us. You all know that I love talking about the latest technology and research around fertility, and this conversation is going to be jam packed with great info. Read the full show notes on Dr. Aimee's website. Dr. Mathew Leonardi's website click here. Do you have questions about IVF?Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, May 1, 2023 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom.   Get Dr. Aimee's brand new Conception Kit here. Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org. Other ways to connect with Dr. Aimee and The Egg Whisperer Show: Subscribe to my YouTube channel for more fertility tips!Subscribe to the newsletter to get updates

How well are your neurons communicating with each other? I'll bet they can do a better job. We'd all like our brains to be as optimal as possible and some times they need re-training. When they're heavily challenged by the crazy times we're in, they can become confused and need re-alignment. Neurofeedback uses non-invasive, positive reinforcement methods to target brain waves. They can reveal how the neurons are getting along or not. These neurotherapy methods can then help them find their way back into alignment. Marty Wuttke has been working in this field for over 40 years and has a lot to tell us about the great advances in recent times.

The Latest Advances in the Health Care Industry, Artificial Intelligence in 2023, The US Housing Market in 2023

The Latest Advances in the Health Care Industry, Artificial Intelligence in 2023, The US Housing Market in 2023See omnystudio.com/listener for privacy information.

Exploring the Latest Advances in Curing Blindness, Anti-Aging Cells, and the Debate Around Banning TikTok. Plus, a Journey to the Future of Generation Star ShipsAll the links: Charity CornNo time like the presentTikTok on the Clock Generation ships—Want the YouTube Version: https://www.youtube.com/c/TheresaSubforThat—Follow us online:Twitter: @sub4thatInstagram: @subforthatTikTok: SubforThatPodcastEmail: theres@subforthat.com—Scott on Twitter: @ScottGurrolaWilly on Twitter: @WildMN293Scott Gurrola & Willy Mattson Copyright 2023 All rights reserved.

In this interview I am speaking with Dr. Tamish Lewis, MD about various treatment solutions for Long-COVID that can help manage symptoms and improve quality of life. We touch upon most common symptoms, such as dysautonomia, hormone and menstrual cycle dysregulation, fatigue, breathing difficulties, autoimmune reaction, vascular inflammation and specific treatment solutions for each symptom. Long-Covid is a consequence of SARS-CoV-2 infection. For most long haulers, Long-COVID impairs every aspect of their lives. If you are LONG-COVID sufferer yourself, a family member or a partner of someone who is, or a clinician looking for a resource, information we discuss in this episode can be a life-changer. I have personally tried many therapies described in this podcast in my road to recovery from Long-COVID Dr. Tam Lewis can be found on instagram @drtam Wellgevity https://www.wellgevity.com UK MS Society is offering Hyperbaric Therapy across UK More benefits of Hyperbaric Oxygen Therapy on my Youtube channel @hyperbaric Hyperbaric Living with Dr.Masha on Instagram @hyperbaric_living About me: I'm Dr. Masha, Naturopathic doctor and Hyperbaric expert. I teach people how to combine natural therapies with lifestyle changes to regain their health, live longer and be healthy for as long as possible. I have a special interest in Hyperbaric Oxygen Therapy and I am on a mission to raise awareness about the benefits of HBOT. This podcast is for informational purposes only and does not substitute a medical advice. The information presented is not meant to diagnose, treat, cure, or prevent disease. We recommend you seek the advice of a licensed healthcare practitioner before beginning any natural, complimentary, or conventional treatment. #hyperbaricoxygentherapy #hyperbaricchamber #hbot #mhbot #functionalmedicine #longcovidy #dysautonomia #POTS #autoimmunedisease #LDN #postinfectioussyndrome #brainfog #fatigue #hyperbarictherapy #breathingdifficulties #drtam #wellgevity

Today on the Egg Whisperer Show, I'm delighted to be joined by Dr. Mathew Leonardi . As a world expert in endometriosis, Dr. Leonardi is known for finding innovative ways to diagnose and treat endometriosis. Additionally, he is an avid researcher, and I can't wait for him to share his research with us. You all know that I love talking about the latest technology and research around fertility, and this conversation is going to be jam packed with great info. Read the full show notes on Dr. Aimee's website. Do you have questions about IVF? Join Dr. Aimee for The IVF Class at The Egg Whisperer School. The next live class call is on Monday, October 17, 2022 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom. Dr. Mathew Leonardi's website click here. Subscribe to my YouTube channel for more fertility tips! Join Egg Whisperer School Checkout the podcast Subscribe to the newsletter to get updates Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org.

With Jaye Sciullo, Michigan Executive Director of Susan G. Komen & Dr. Shoshana Hallowell, Surgical Oncologist at Ascension Health   What goes through your mind when you hear the word “cancer?” Fear of the unknown? How will this affect my loved ones? Will I survive? Second only to heart disease, cancer is a leading cause of death for adults in the United States. Although the word “cancer” in itself is scary, not all cancers are alike. In fact, there are types of cancer that are easier to treat and often result in full remission.   With more than 290,000 new diagnoses predicted for 2022 alone, breast cancer is the second leading cause of death in women. Approximately 13% of women in the U.S. will be diagnosed with breast cancer at some point in their lives. This means there is a 1-in-8 chance a woman living in the U.S. will develop breast cancer. But this also means there is a 7-in-8 chance she'll never have the disease.   Thankfully, advances in genetic testing, immunotherapy, and other promising new trials are transforming the way we treat breast cancer. Today, we're going to talk with Jaye Sciullo and Dr. Shoshana Hallowell, a surgical oncologist with Ascension Health. Jaye is the Executive Director for the Michigan chapter of Susan G. Komen, the world's leading breast cancer organization. They're with us today to answer our questions and tell us about the latest advances in breast cancer treatment.   What You'll Hear on This Episode: When did Jaye first become involved with Susan G. Komen? How difficult is it for Jaye to put herself in the shoes of the women she represents? What are the different types of breast cancer? Why is breast cancer often harder to treat than other cancers? Besides not smoking, what are other things can we do to lessen our risk of cancer? How important are mammograms? What exactly are the BRCA genes and what does it mean? How does Susan G. Komen help patients and families? What do you recommend for friends and family members who want to help support co-survivors and patients? Some promising information about new trials and treatments. What role do diet and exercise play in developing and progressing cancer? What is a smart bomb? All about the 2022 Komen Detroit Race for the Cure.   Today's Takeaway: A cancer diagnosis is life-changing, and we're often filled with fear and uncertainty as to what may lie ahead. But the mission of the Susan G. Komen organization is dedicated to making sure that no breast cancer patient has to go it alone. Since Susan G. Komen was founded in 1986, we have seen a 40% reduction in breast cancer mortality. The Komen organization is committed to being alongside the patient throughout the entirety of their cancer journey. In addition to providing financial support when needed, there are virtual nurse navigators who will assist patients in preparing for doctor appointments and provide a list of necessary questions to ask. Afterward, they can also help explain the mass of information that patients receive. Based on the statistics shared today, we all probably know someone battling breast cancer. We are hopeful that soon we can find a cure so that future generations can look forward to a life without this deadly disease. Remember that every single day is a gift and even when life throws us a curveball, we have the gift of freedom of choice. We get to choose our response and how we handle adversity is up to each and every one of us. We can choose to fight our battle with grace, dignity, and courage, knowing that we will find the support we need every step of the way. I'm Florine Mark and that's “Today's Takeaway.”   Quotes: “I think that it's difficult these days to not be touched by breast cancer in some way.” — Jaye “Breast cancer is harder to treat because it's very complex.” — Dr. Hallowell “There are many things that you can do to lessen your risk of developing cancer. I think the most important is to be aware of your own health.” — Dr. Hallowell “70% of breast cancers diagnosed in women under the age of 50 have been found by the women themselves.” — Dr. Hallowell “Screening is important. The modality in which you're screened is also important.” — Dr. Hallowell “Susan G. Komen is committed to a world without breast cancer.” — Jaye “Our mission is to save lives by meeting the most critical needs of our communities and investing in breakthrough research to prevent and cure breast cancer.” — Jaye “When you're newly diagnosed, you don't know what you don't know. And it's often a very winding path of self-discovery and learning how to advocate for yourself.” — Jaye “No two paths are alike.” — Jaye “Women with dense breast tissue need additional screening and women that are high risk need additional screening.” — Dr. Hallowell   Brought to You By: Gardner White Furniture   Mentioned in This Episode:  Susan G. Komen of Michigan 2022 Komen Detroit Race for the Cure Dr. Shoshana Hallowell — Ascension

What are the latest advances in lung cancer treatment? In April 2022, findings from the large scale CheckMate 816 clinical trial were presented to the American Association for Cancer Research. The trial looked into the effectiveness of immunotherapy drug Nivolumab, combined with chemotherapy to treat lung cancer patients. The findings were promising, showing that this particular treatment combination can delay the progression or return of cancer.    How common is lung cancer and how does it start? What are the most prominent treatment options? Should we expect this treatment to become used widely?  In under 3 minutes, we answer your questions ! To listen to the last episodes, you can click here : What is Roe vs Wade, the ruling that guaranteed American women abortion rights? Could tourism quotas help preserve endangered local environments? Is bikini waxing harmful for your health? A podcast written and realised by Joseph Chance. In partnership with upday UK. Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode of Cut to the Chase:, Dr. Adam Liebovich discusses the exiting new developments in nuclear fusion.   For the past 100 years, fusion has always been "30 years away" but with venture capital money pouring into it, including Bill Gates, there is serious talk that we might be a few years away from getting to the point where fusion becomes more feasible.   Nuclear fusion would provide nearly limitless emissionless energy without some of the big problems.    Although Putin taking over the largest nuclear reactor in Europe might reenergize the anti nuke crowd, it is key to understand all the benefits of nuclear fusion before we run that process off the table.  

How have the most recent advances in wet AMD therapy changed the treatment landscape for clinicians? In this debut episode of the third season of “The Art of Drug Choice,” moderator Arshad M. Khanani, MD, MA, is joined by Lejla Vajzovic, MD, and Joseph M. Coney, MD, for a discussion about choosing patients who are best suited for the recently approved therapies, and for a preview of how biosimilars could affect treatment decisions. After the break, Dr. Coney shares the case of a patient whose need to extend treatment intervals was addressed by switching to a new anti-VEGF agent. This editorially independent podcast is supported with advertising.

Rheumatoid arthritis (RA) is earmarked by systemic inflammation and damage to joints and surrounding tissues. This can be brought on by many different ways including injury and/or infection as a triggers, genetic predispositions and environmental factors to name a few. What is poorly understood is the role that hormones and mineral deficiency play in RA. We will also explore the impact of cortisol deficiency as a factor for chronic inflammation in shoulder/hip joints and immune function control. This is our first episode in 2022 so we want to start off with the most commonly asked subject and try to explain why patients with RA, Knee Osteoarthritis, Psoriatic Arthritis, Gout or Lupus should have regular lab tests & assessments to better figure out optimal treatment options for regenerating tissues and eliminating deficiencies. Links from the show notes: https://www.mayoclinic.org/diseases-conditions/rheumatoid-arthritis/symptoms-causes/syc-20353648 https://www.nhs.uk/conditions/rheumatoid-arthritis/causes/ https://stemcellthailand.org/therapies/joint-inflammation-arthritis-osteoarthritis-gout/ https://arthritisaustralia.com.au/types-of-arthritis/rheumatoid-arthritis/ https://www.hopkinsarthritis.org/arthritis-info/rheumatoid-arthritis/ra-treatment/ Previous Episodes: Rotator Cuff Tears Shoulder & Elbow Pain : Do You Need Surgery? Balancing Work & Life After Suffering a Spinal Cord Injury Regenerative vs Restorative Surgical Options for Knee Arthritis and Cartilage Injuries Advances in the Diagnosis and Treatment of Cervical or Lumbar Spine Degenerative Disease Disclaimer - Nothing you hear on the Inside Orthopedics Today Podcast is intended as medical advice. You should always consult a physician before making any changes to your health plan. If the podcast has helped you to live better please tell someone else how to find the show and consider leaving a rating and review on iTunes.